Ikarian Capital, LLC
Q3 2025 13F Holdings
- Locationdallas, TX
- Num holdings
169
- Value ($000)
$990,388
- Date Filed 11/14/2025
- Form type13F-HR
- CIK 0001778253
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
U UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | $87.95M | 9 % | 209,800 | put | |
K SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | $75.15M | 8 % | 750,000 | put | |
G GENMAB A/S | SPONSORED ADS | 372303206 | $53.02M | 5 % | 175,000 | ||
B BRISTOL-MYERS SQUIBB CO | COM | 110122108 | $36.08M | 4 % | 800,000 | put | |
ABIVAX SA | SPONSORED ADS | 00370M103 | $33.42M | 3 % | 396,098 | ||
UNIQURE NV | CALL | N90064901 | $31.26M | 3 % | 535,600 | call | |
I IONIS PHARMACEUTICALS INC | COM | 462222100 | $27.16M | 3 % | 415,163 | ||
C CIDARA THERAPEUTICS INC | COM NEW | 171757206 | $26.59M | 3 % | 277,704 | ||
S SCHOLAR ROCK HLDG CORP | COM | 80706P103 | $20.91M | 2 % | 561,600 | call | |
MAZE THERAPEUTICS INC | COM | 578784100 | $19.21M | 2 % | 740,825 |
Rows Per Page
10
- 10
- 50
- 100